HLA-B and mitochondrial DNA depletion syndrome 4a: In historic studies before the identification of HLA-B*5701 as a genetic risk factor, AHS occurs in around 5% of patients treated with abacavir with a mortality rate of around 3 per 1000 (Bannister et al. 2008; Hetherington et al. 2001).